drugset / Trial / NCT02418845
A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this clinical trial is to test the safety and efficacy of the oral investigational new drug, SYM-1219 for the treatment of bacterial vaginosis.
Timeline
- Start
- 2015-05-28
- Primary completion
- 2015-10-05
- Completion
- 2015-12-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Secnidazole | Small molecule | 2 g | Oral |